HOME › DRUGS › AVAPRITINIB
ACTIVE SUBSTANCE / INN

AVAPRITINIB

Brand name(s): Ayvakyt, AYVAKIT
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Gastrointestinal Stromal Tumors
NDA212608
ACTIVE SUBSTANCE
Avapritinib
REGULATORS
FDA · EMA
SPONSORS / MAH
Blueprint Medicines (Netherlands) B.V., BLUEPRINT MEDICINES
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
AYVAKITNDA212608BLUEPRINT MEDICINESPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AyvakytBlueprint Medicines (Netherlands) B.V.Authorised24/09/2020Gastrointestinal Stromal Tumors

FULL INTELLIGENCE ON AVAPRITINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →